Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2014
10/09/2014US20140301945 Human anti-sod1 antibodies
10/08/2014EP2787081A1 Drug containing carrier into cell for forming immune complex
10/08/2014EP2786756A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786755A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786754A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786753A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786750A1 Agent for reducing adverse side effects of kinase inhibitor
10/08/2014EP2786658A1 Sterilizer, oral sterilizer, sterilization method, sterilization apparatus, and sterilizer evaluation method
10/08/2014EP2785332A1 A process for the preparation of solid dispersion of lopinavir and ritonavir
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853369 Anti-Axl antibodies and methods of use
10/07/2014US8853357 High purity lipopeptides
10/07/2014US8853275 Concurrent therapy regime/regimen for the treatment of acne related diseases
10/07/2014US8853263 Co-therapy for the treatment of epilepsy and related disorders
10/07/2014US8853256 Composition for preventing the occurrence of cardiovascular event in multiple risk patient
10/07/2014US8853245 Orally bioavailable dabigatran prodrugs for the treatment of diseases
10/07/2014US8853229 Composition containing statins and omega-3 fatty acids
10/07/2014US8853227 Methotrexate adjuvants to reduce toxicity and methods for using the same
10/07/2014US8853222 Treatment of herpes virus related diseases
10/07/2014US8853217 Compounds useful as inhibitors of ATR kinase
10/07/2014US8853204 Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein
10/07/2014US8853203 Diazepinone derivatives
10/07/2014US8853197 Nitrogen containing compounds
10/07/2014US8853189 Antispasmodic 1,2-Diols and 1,2,3-triols
10/07/2014US8853154 Fibronectin based scaffold domain proteins that bind to myostatin
10/07/2014US8852879 Materials and methods for the detection of nitrated fibrinogen
10/07/2014US8852860 Sperm-specific cation channel, CatSper1 and uses therefor
10/07/2014US8852636 Pharmaceutical compositions for the coordinated delivery of NSAIDs
10/07/2014US8852626 Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
10/07/2014US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells
10/07/2014US8852606 Capsular polysaccharide solubilisation and combination vaccines
10/07/2014US8852591 Combination of BLyS and/or APRIL inhibition and immunosuppressants for treatment of autoimmune disease
10/07/2014US8852582 Compositions comprising glutathione reductase and oxidized glutathione
10/07/2014US8852566 Compositions and methods for preferential distribution of active agents to injury sites
10/07/2014US8852551 Methods to impair hematologic cancer progenitor cells and compounds related thereto
10/02/2014WO2014160940A2 Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders
10/02/2014WO2014160872A2 Throat gargle tablet and method of use thereof
10/02/2014WO2014160196A2 Sonochemical induction of abca1 expression and compositions therefor
10/02/2014WO2014160071A1 Methods and compositions for the treatment of glutamine-addicted cancers
10/02/2014WO2014160034A1 Aldehyde dehydrogenase-1 modulators and methods of use thereof
10/02/2014WO2014159940A1 Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor
10/02/2014WO2014159703A2 N-acetyl cysteine compositions in the treatment of systemic lupus erythematosus
10/02/2014WO2014159679A1 Methods for using lubiprostone to absorb fluid from the subretinal space
10/02/2014WO2014158875A1 Novel therapy for prostate carcinoma
10/02/2014WO2014157547A1 Composition for oral cavity
10/02/2014WO2014157429A1 Method for producing protein
10/02/2014WO2014157380A1 Therapeutic agent for wounds or fibrosis
10/02/2014WO2014156958A1 Nano-capsule, composition, polynucleotide, recombinant vector, and transformant
10/02/2014WO2014156339A1 Postprandial gastrokinetic agent
10/02/2014WO2014155370A1 Kit with multiple nutritional supplements and a method for assembling thereof
10/02/2014WO2014155184A1 Treatment for parkinson's disease
10/02/2014WO2014155138A1 Optimization and therapeutic valorization of the symptomatic treatment of alzheimer's disease with rivastigmine, galantamine or donepezil, by selected aminotetrahydrofurans acting as mixed sigma-1 / muscarinic ligands
10/02/2014WO2014155135A1 Methods for the treatment of autoimmune diseases
10/02/2014WO2014154804A1 Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
10/02/2014US20140296836 Gold-in-silicon nanoassembly for thermal therapy and methods of use
10/02/2014US20140296493 METHOD OF TREATING DEPRESSION USING A TNFa ANTIBODY
10/02/2014US20140296326 Epidermal growth factor receptor (egfr) and methods of use in adenoviral-associated virus type 6 (aav6) transduction
10/02/2014US20140296304 Pharmaceutically Active Disubstituted Pyridine Derivatives
10/02/2014US20140296302 Methods For Treating Inflammation
10/02/2014US20140296295 2-alkoxy-substituted dicyanopyridines and their use
10/02/2014US20140296292 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
10/02/2014US20140296278 5-nonyloxytryptamine and related intracellular ph acidifiers for the treatment and prevention of cancer
10/02/2014US20140296272 Thieno [2, 3-b] pyridine derivatives as viral replication inhibitors
10/02/2014US20140296270 STAT3 Inhibitors
10/02/2014US20140296266 Therapeutic compounds
10/02/2014US20140296264 Mgmt inhibitor combinations for the treatment of neoplastic disorders
10/02/2014US20140296262 Method to Treat Premature Ejaculation in Humans
10/02/2014US20140296259 4-Amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and their use as antiviral active substances
10/02/2014US20140296240 Substituted aminopropionic derivatives as neprilysin inhibitors
10/02/2014US20140296236 Quinolines as fgfr kinase modulators
10/02/2014US20140296231 Amino-substituted imidazopyridazines
10/02/2014US20140296225 Inhibitors of the Renal Outer Medullary Potassium Channel
10/02/2014US20140296224 Quinoline derivatives as pi3 kinase inhibitors
10/02/2014US20140296217 Medicaments for the treatment or prevention of fibrotic diseases
10/02/2014US20140296203 Novel compounds that are erk inhibitors
10/02/2014US20140296197 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
10/02/2014US20140296196 Nk1 antagonists
10/02/2014US20140296195 Method for the treatment of central nervous system cancers and compositions related thereto
10/02/2014US20140296191 Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
10/02/2014US20140296166 Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction
10/02/2014US20140296165 Use of tight junction antagonists to treat inflammatory bowel disease
10/02/2014US20140296164 Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
10/02/2014US20140296159 Method for Therapeutic Replenishment and Enrichment of Ocular Surface Lubrication
10/02/2014US20140296157 Compositions and methods for preparing a subject for organ or non-organ implantation
10/02/2014US20140296154 Method of preventing development of psoriatic lesions
10/02/2014US20140296143 Angiotensin-(1-7) As A Chemoprevention Agent
10/02/2014US20140296141 Compositions and Methods for Treating Obesity, Obesity Related Disorders and for Inhibiting the Infectivity of Human Immunodeficiency Virus
10/02/2014US20140296133 Sila analogs of oxazolidinone derivatives and synthesis thereof
10/02/2014US20140296130 Novel inhibitors of mammalian tight junction opening
10/02/2014US20140296128 Materials and methods for treatment of cancer and identification of anti-cancer compounds
10/02/2014US20140295009 Composition and method for boosting immunological response
10/02/2014US20140294995 Lozenge for treating sore throat, hoarseness and associated dry cough, and inflammatory diseases of the oral and pharyngeal cavity
10/02/2014US20140294994 Pharmaceutical composition for elimination of cancer stem cells
10/02/2014US20140294990 Throat gargle tablet and method of use thereof
10/02/2014US20140294987 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
10/02/2014US20140294973 Pharmaceutical compositions of hydrophobic camptothecin derivatives
10/02/2014US20140294964 Compositions and methods for treating cancer with dacarbazine nanoemulsions
10/02/2014US20140294931 Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
10/02/2014US20140294923 Acth for treatment of migraine headache
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 1151